Fenoldopam approved in the US and will be marketed by Neurex Co. It is available as 10 mg/mL ampules containing 5 mL. The drug must be diluted before administration as an intravenous infusion. How it works Fenoldopam (Corlopam) is a dopamine1-like receptor agonist and binds with moderate affinity to the alpha2-adrenoreceptors. Fenoldopam does not exhibit [...]
